FDA To Seek More Power Over Compounders At Hearing

By Rachel Slajda (November 13, 2012, 8:04 PM EST) -- The U.S. Food and Drug Administration will make the case to Congress on Wednesday that it should have more authority over compounding pharmacies, but it is likely to be met with skepticism over how well it used its existing oversight of the compounder tied to a recent deadly meningitis outbreak....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.

A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!